GSK plc 13D and 13G filings for Wave Life Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:32 pm Purchase | 2024-09-30 | 13G | Wave Life Sciences Ltd. WVE | GSK plc | 16,775,691 11.200% | 16,775,691 (New Position) | Filing |
| 2024-02-06 5:07 pm Purchase | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | GSK plc | 13,983,761 11.500% | 3,300,000 (+30.89%) | Filing |
| 2023-01-30 4:37 pm Purchase | 2023-01-23 | 13G | Wave Life Sciences Ltd. WVE | GSK plc | 10,683,761 10.950% | 10,683,761 (New Position) | Filing |